News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Roberts M Scot
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/02/2023 |
4
| Roberts M Scot (Chief Scientific Officer) has filed a Form 4 on Altimmune, Inc.
Txns:
| Granted 568 shares
@ $2.81, valued at
$1.6k
|
|
02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2023 |
4
| Roberts M Scot (Chief Scientific Officer) has filed a Form 4 on Altimmune, Inc.
Txns:
| Granted 105,000 options to buy
@ $12.88, valued at
$1.4M
Granted 37,100 restricted stock units
@ $0 |
|
08/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/04/2020 |
4
| Roberts M Scot (Chief Scientific Officer) has filed a Form 4 on Altimmune, Inc.
Txns:
| Granted 3,698 shares
@ $1.46, valued at
$5.4k
|
|
01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/27/2019 |
4
| Roberts M Scot (Chief Scientific Officer) has filed a Form 4 on Altimmune, Inc.
Txns:
| Granted 38,000 options to buy
@ $2.95, valued at
$112.1k
|
|
01/04/2019 |
4
| Roberts M Scot (Chief Scientific Officer) has filed a Form 4 on Altimmune, Inc.
Txns:
| Granted 30,000 options to buy
@ $2.6, valued at
$78k
|
|
05/23/2018 |
4
| Roberts M Scot (Chief Scientific Officer) has filed a Form 4 on Altimmune, Inc.
Txns:
| Granted 50,016 options to buy
@ $0.445, valued at
$22.3k
Exercised 55,120 options to buy
@ $0.08, valued at
$4.4k
|
|
02/23/2018 |
4
| Roberts M Scot (Chief Scientific Officer) has filed a Form 4 on Altimmune, Inc.
Txns:
| Bought 449 shares
@ $4.42, valued at
$2k
|
|
09/26/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/08/2017 |
4
| Roberts M Scot (Chief Scientific Officer) has filed a Form 4 on Altimmune, Inc.
Txns:
| Granted 55,120 options to buy
@ $0.08, valued at
$4.4k
Granted 8,956 options to buy
@ $0.59, valued at
$5.3k
Granted 8,956 options to buy
@ $2.59, valued at
$23.2k
Granted 11,235 options to buy
@ $13.38, valued at
$150.3k
|
|
05/08/2017 |
3
| Roberts M Scot (Chief Scientific Officer) has filed a Form 3 on Altimmune, Inc. |
|
|